USPTO serial 79295544
LEMZKYO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 5, 2021
- Examiner
- SMITH, TARYN E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with LEMZKYO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LABORATORIOS FARMACEUTICOS ROVI, S.A.
E-28037 Madrid, ES
Other trademarks owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.
LABORATORIOS FARMACEUTICOS ROVI, S.A.
E-28037 Madrid, ES
Other trademarks owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.
LABORATORIOS FARMACEUTICOS ROVI, S.A.
E-28037 Madrid, ES
Other trademarks owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products, namely, antibiotics, analgesics, anesthetics, amino acids for medical use, antiseptics, tranquilizers, collyriums, digestives for pharmaceutical purposes, laxatives; chemical products for medical use, being pharmaceuticals for treating schizophrenia; chemical pharmaceuticals preparations for the treatment of diseases of the central nervous system; tonics being medicines for the treatment of headache; tranquillizers; soporifics; antipsychotics; medicated serums for the treatment of eczema; hormones; oral contraceptives; vaccines, syringes, vials, cartridges or carpules and ampoules for medical purposes containing pharmaceutical products in the nature of antipsychotics; pharmaceutical implants for delivering insulin, namely, implantable subcutaneous drug delivery devices sold filled with insulin; sustained release medicine implants for delivering contraceptives, namely, implantable subcutaneous sustained release drug delivery devices sold filled with pharmaceutical preparations for contraceptive use; oncological preparations being pharmaceuticals for the treatment of cancer; preparations for the treatment of diseases of the central nervous system; preparations for the treatment of schizophrenia; preparations for the treatment of hormonal disorders; pharmaceutical preparations for the treatment of allergies, for the treatment of the skin wounds, thrombosis, coagulation diseases, infections, influenza, pain and inflammation; tranquilizers, antidepressants, anxiolytics; chemical products for medical use, being pharmaceuticals for treating schizophrenia; chemical pharmaceuticals for the treatment of diseases of the central nervous system; disposable syringes sold pre-filled with pharmaceutical preparations for treatment of central nervous system diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.
- Other trademarks owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.
- Other trademarks owned by LABORATORIOS FARMACEUTICOS ROVI, S.A.
- Other trademarks in Class 005
- Similar marks named LEMZKYO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 25, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 27, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 27, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 27, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 27, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 27, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 15, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 24, 2022 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 24, 2022 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Jan 5, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 5, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 1, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 20, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 20, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 9, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 30, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 30, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 14, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 3, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 3, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 3, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 3, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 16, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 15, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 27, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 11, 2020 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Dec 4, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 24, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 20, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 15, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 8, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |